Cytokinetics, Inc. (CYTK)
63.37
+1.03
(+1.65%)
USD |
NASDAQ |
Feb 09, 16:00
63.37
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics EPS Diluted (Quarterly) : -2.552 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Molina Healthcare, Inc. | -3.150 |
| Bristol Myers Squibb Co. | 0.5326 |
| Fortrea Holdings, Inc. | -0.1743 |
| Lifecore Biomedical, Inc. | -0.2918 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -306.18M |
| Revenue (Quarterly) | 1.936M |
| Total Expenses (Quarterly) | 308.11M |
| Enterprise Value | 7.853B |
| Gross Profit Margin (Quarterly) | -38.38% |
| Profit Margin (Quarterly) | -15.81K% |
| Earnings Yield | -9.96% |
| Normalized Earnings Yield | -8.714 |